Malondialdehyde plasma concentration correlates with declarative and working memory in patients with recurrent depressive disorder

Molecular Biology Reports

Volumn 39, Issue 5, 2012, Pages 5359-5366

  Talarowska, Monika ^a   Gałecki, Piotr ^a   Maes, Michael ^b   Gardner, Ann ^c   Chamielec, Marcelina ^a   Orzechowska, Agata ^a   Bobińska, Kinga ^a   Kowalczyk, Edward ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b Piyavate Hospital   (Thailand)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Cognitive functions; Depressive disorders; MDA; Oxidative stress

Indexed keywords

MALONALDEHYDE;

ADULT; AGE; ARTICLE; AUDITORY MEMORY; BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEPRESSION; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; FEMALE; FUNCTIONAL ASSESSMENT; HAMILTON SCALE; HUMAN; MALE; MENTAL PERFORMANCE; MOLECULAR PATHOLOGY; OUTCOME ASSESSMENT; OXIDATIVE STRESS; RECURRENT DISEASE; SPATIAL MEMORY; SYNDROME DELINEATION; TREATMENT DURATION; VERBAL MEMORY; WORKING MEMORY; BLOOD; COGNITION; DEMOGRAPHY; DISEASE COURSE; MIDDLE AGED; NONPARAMETRIC TEST; PATHOPHYSIOLOGY; PHYSIOLOGY; SHORT TERM MEMORY;

ADULT; COGNITION; DEMOGRAPHY; DEPRESSIVE DISORDER; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MALONDIALDEHYDE; MEMORY, SHORT-TERM; MIDDLE AGED; RECURRENCE; STATISTICS, NONPARAMETRIC; YOUNG ADULT;

EID: 84863771490     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-011-1335-8     Document Type: Article

References (51)

1. Talarowska M, Florkowski A, Zboralski K, Berent D, Wierzbiński P, Gałecki P (2010) Auditory-verbal declarative and operating memory among patients suffering from depressive disorders-preliminary study. Adv Med Sci 55(2):317-327
2. Castaneda AE, Suvisaari J, Marttunen M, Perälä J, Saarni SI, Aalto-Setälä T, Aro H, Koskinen S, Lönnqvist J, Tuulio-Henriksson A (2008) Cognitive functioning in a population-based sample of young adults with a history of non-psychotic unipolar depressive disorders without psychiatric comorbidity. J Affect Disord 110(1-2):36-45
3. Gałecki P, Florkowski A, Mrowicka M, Malinowska K, Gałecka E (2007) Calcium ions, glutaminate acid, hypothalamic-pituitaryadrenal axis, calcium dependent ATP-ase as causes of oxidative damage in depression patients-Part I. Pol Merk Lek XXIII (138):466-468
4. Novío S, Núñez M, Amigo G, Freire-Garabal M (2011) Effects of fluoxetine on the oxidative status of peripheral blood leukocytes of restraint-stressed mice. Basic Clin Pharmacol Toxicol. doi: 10.1111/j.1742-7843. 2011.00736
5. Maes M, Galecki P, Chang YS, Berk M (2011) A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness. Prog Neuropsychopharmacol Biol Psychiatry 35(3):676-692
6. Gałecki P, Maes M, Florkowski A, Lewiński A, Gałecka E, Bieńkiewicz M, Szemraj J (2010) An inducible nitric oxide synthase polymorphism is associated with the risk of recurrent depressive disorder. J Neurosci Lett 486(3):184-187
7. Maes M, Leonard B, Fernandez A, Kubera M, Nowak G, Veerhuis R, Gardner A, Ruckoanich P, Geffard M, Altamura C, Galecki P, Berk M (2011) (Neuro)inflammation and neuroprogression as new pathways and drug targets in depression: from antioxidants to kinase inhibitors. Prog Neuropsychopharmacol Biol Psychiatry 35(3):659-663
8. Catena-Dell'Osso M, Bellantuono C, Consoli G, Baroni S, Rotella F, Marazziti D (2011) Inflammatory and neurodegenerative pathways in depression: a new avenue for antidepressant development? Curr Med Chem 18(2):245-255
9. Yang RL, Shi YH, Hao G, Li W, Le GW (2008) Increasing oxidative stress with progressive hyperlipidemia in human: relation between malondialdehyde and atherogenic index. J Clin Biochem Nutr 43(3):154-158
10. Gawryluk JW, Wang JF, Andreazza AC, Shao L, Young LT (2011) Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatricdisorders. Int J Neuropsychopharmacol 14(1):123-130
11. Teyssier JR, Ragot S, Chauvet-Gélinier JC, Trojak B, Bonin B (2011) Expression of oxidative stress-response genes is not activated in the prefrontal cortex of patients with depressive disorder. Psychiatry Res 186(2-3):244-247
12. Atmaca M, Kuloglu M, Tezcan E, Ustundag B (2008) Antioxidant enzyme and malondialdehyde levels in patients with social phobia. Psychiatry Res 159(1-2):95-100
13. Yao JK, Leonard S, Reddy R (2006) Altered glutathione redox state in schizophrenia. Dis Markers 22:83-93
14. Kuloglu M, Ustundag B, Atmaca M, Canatan H, Tezcan AE, Cinkilinc N (2002) Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder. Cell Biochem Funct 20(2):171-175
15. Behl A, Swami G, Sircar SS, Bhatia MS, Banerjee BD (2010) Relationship of possible stress-related biochemical markers to oxidative/antioxidative status in obsessive-compulsive disorder. Neuropsychobiology 61(4):210-214
16. Evola M, Hall A, Wall T, Young A, Grammas P (2010) Oxidative stress impairs learning and memory in apoE knockout mice. Pharmacol Biochem Behav 96(2):181-186
17. Ghadrdoost B, Vafaei AA, Rashidy-Pour A, Bandegi AR, Motamedi F, Haghighi S, Samani HR, Pahlvan S (2011) Protective effects of saffron extract and its active constituent crocin against oxidative stress and spatial learning and memory deficits induced by chronic stress in rats. Eur J Pharmacol May 18 [Epub ahead of print]
18. ICD-10 Classification of Mental & Behavioural Disorders (1993) World Health Organization
19. Patten S (1997) Performance of the composite international diagnostic interview short form for major depression in community and clinical samples. Chron Dis Can 3:18-24
20. Taylor D, Paton C, Kerwin R (2007) The Maudsley prescribing guidelines. Informa Healthcare, London
21. Reitan RM (1958) The relation of the trail making test to organic brain damage. J Cons Psychol 19:393-394
22. Sánchez-Cubillo I, Periáñez J, Adrover-Roig D, Rodríguez-Sánchez J, Ríos-Lago M, Tirapu J (2009) Construct validity of the trail making test: role of task-switching, working memory, inhibition/interference control, and visuomotor abilities. JINS 15:438-451
23. Stroop JR (1935) Studies of interference in serial verbal reactions. J Exp Psychol 18:643-662
24. Audenaert K, Lohorte P, Brans B, Van Laere K, Goethals I, van Heeringen K, Diereckx R (2001) The classical Stroop interference task as a prefrontal activation probe: a validation study using 99Tc"'-ECD brain SPECT. Nucl Med Commun 22:135-143
25. Vendrell P, Junque C, Pujol J, Jurado MA, Molet J, Grafman J (2005) The role of prefrontal regions in Stroop task. Neuropsychologia 33:341-352
26. Wolfram H, Neumann J, Wieczorek V (1986) Psychologische leistungstests in der neurologie und psychiatrie. VEB Georg Thieme, Leipzig
27. Łuria A (1976) Neuropsychology. PZWL, Warsaw
28. McDowd J, Hoffman L, Rozek E, Lyons KE, Pahwa R, Burns J, Kemper S (2011) Understanding verbal fluency in healthy aging, Alzheimer's disease, and Parkinson's disease. Neuropsychology 25(2):210-225
29. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56-62
30. Moonseong H, Murphy CF, Meyers BS (2007) Relationship between the hamilton depression rating scale and the Montgomery- A° sberg depression rating scale in depressed elderly. Am J Geriatr Psychiatry 15:899-905
31. Demyttenaere K, De Fruyt J (2003) Getting what you ask for: on the selectivity of depression rating scales. Psychothery Psychosom 72:61-70
32. Placer ZA, Cushman LL, Johnson BC (1966) Estimation of product of lipid peroxidation (malonyl dialdehyde) in biochemical systems. Anal Biochem 16:359-364
33. Bilici M, Efe H, Köroǧlu MA, Uydu HA, Bekaroǧlu M, Deǧer O (2001) Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments. J Affect Disord 64(1):43-51
34. Kuloglu M, Atmaca M, Tezcan E, Gecici O, Tunckol H, Ustundag B (2002) Antioxidant enzyme activities and malondialdehyde levels in patients with obsessive-compulsive disorder. Neuropsychobiology 46(1):27-32
35. Gałecki P, Szemraj J, Bieńkiewicz M, Zboralski K, Gałecka E (2009) Oxidative stress parameters after combined fluoxetine and acetylsalicylic acid therapy in depressive patients. Hum Psychopharmacol 24(4):277-286
36. Mutlu-Türkoǧlu U, Ilhan E, Oztezcan S, Kuru A, Aykaç-Toker G, Uysal M (2003) Age-related increases in plasma malondialdehyde and protein carbonyl levels and lymphocyte DNA damage in elderly subjects. Clin Biochem 36(5):397-400
37. Bartosz G (2010) Non-enzymatic antioxidant capacity assays: limitations of use in biomedicine. Free Radic Res 44(7):711-720
38. Delibas N, Ozcankaya R, Altuntas I (2002) Clinical importance of erythrocyte malondialdehyde levels as a marker for cognitive deterioration in patients with dementia of Alzheimer type: a repeated study in 5-year interval. Clin Biochem 35(2):137-141
39. Kotan VO, Sarandol E, Kirhan E, Ozkaya G, Kirli S (2011) Effects of long-term antidepressant treatment on oxidative status in major depressive disorder: a 24-week follow-up study. Prog Neuropsychopharmacol Biol Psychiatry Apr 15 [Epub ahead of print]
40. Arai H, Takechi H, Wada T, Ishine M, Wakatsuki Y, Horiuchi H, Murayama T, Yokode M, Tanaka M, Kita T, Matsubayashi K, KumeN(2006) Usefulness of measuring serum markers in addition to comprehensive geriatric assessment for cognitive impairment and depressive mood in the elderly. Geriatr Gerontol Int 6(1):7-14
41. Gao X, Lai C, Scott T, Shen J, Cai T, Ordovas JM, Tucker KL (2010) Urinary 8-hydroxy-2-deoxyguanosine and cognitive function in Puerto Rican adults. Am J Epidemiol 172(3):271-278
42. Torres LL, Quaglio NB, de Souza GT, Garcia RT, Dati LM, Moreira WL, de Melo Loureiro AP, de Souza-Talarico JN, Smid J, Porto CS, de Campos Bottino CM, Nitrini R, de Moraes Barros SB, Camarini R, Marcourakis T (2011) Peripheral oxidative stress biomarkers in mild cognitive impairment and Alzheimer's disease. J Alzheimers Dis May 13 [Epub ahead of print]
43. Padurariu M, Ciobica A, Hritcu L, Stoica B, Bild W, Stefanescu C (2010) Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and Alzheimer's disease. Neurosci Lett 469(1):6-10
44. Ambali SF, Idris SB, Onukak C, Shittu M, Ayo JO (2010) Ameliorative effects of vitamin C on short-term sensorimotor and cognitive changes induced by acute chlorpyrifos exposure in Wistar rats. Toxicol Ind Health 26(9):547-558
45. Umur EE, Oktenli C, Celik S, Tangi F, Sayan O, Sanisoglu YS, Ipcioglu O, Terekeci HM, Top C, Nalbant S, Kucukardali Y (2011) Increased iron and oxidative stress are separately related to cognitive decline in elderly. Geriatr Gerontol Int. doi: 10.1111/j.1447-0594.2011.00694.x
46. Konarski JZ, McIntyre RS, Kennedy SH, Rafi-Tari S, Soczynska JK, Ketter TA (2008) Volumetric neuroimaging investigations in mood disorders: bipolar disorder versus major depressive disorder. Bipolar Disord 10:1-37
47. Fuchs E, Flügge G (2002) Social stress in tree shrews: effect on physiology, brain function and behavior of subordinate individuals. Pharmacol Biochem Behav 73:247-258
48. Cai XH, Zhou YH, Zhang CX, Hu LG, Fan XF, Li CC, Zheng GQ, Gong YS (2010) Chronic intermittent hypoxia exposure induces memory impairment in growing rats. Acta Neurobiol Exp (Wars) 70(3):279-287
49. Ravindra PS, Shashwat S, Suman K (2004) Free radicals and oxidative stress in neurodegenerative diseases: relevance of dietary antioxidants. JIACM 5:218-225
50. Sarandol A, Sarandol E, Eker SS, Erdinc S, Vatansever E, Kirli S (2007) Major depressive disorder is accompanied with oxidative stress: short-term antidepressant treatment does not alter oxidative- antioxidative systems. Hum Psychopharmacol 22(2):67-73
51. Gałecki P, Szemraj J, Bieńkiewicz M, Florkowski A, Gałecka E (2009) Lipid peroxidation and antioxidant protection in patients during acute depressive episodes and in remission after fluoxetine treatment. Pharmacol Rep 61(3):436-444